Drug Discovery

Why Does GABA Fuel Glioblastoma Growth in Women?
Research & Development Why Does GABA Fuel Glioblastoma Growth in Women?

Medical science has traditionally operated under the assumption that a brain tumor behaves with the same lethal mechanics regardless of whether the patient is male or female. Yet, statistics have long told a different story, revealing that glioblastoma is not only more common in men but also

Scientists Map Single-Cell Proteome for Heart Regeneration
Research & Development Scientists Map Single-Cell Proteome for Heart Regeneration

The human heart remains one of the few organs incapable of mounting a successful self-repair response following a major traumatic event like a myocardial infarction. While the liver can regrow and the skin heals seamlessly, the adult mammalian heart typically responds to injury by producing stiff,

How Can AI and CRISPR Unlock Living Drugs for Solid Tumors?
Research & Development How Can AI and CRISPR Unlock Living Drugs for Solid Tumors?

The recent awarding of the European Research Council Advanced Grant to Christoph Bock represents a pivotal shift in the trajectory of modern oncology by prioritizing the development of sophisticated living drugs. These therapies, particularly chimeric antigen receptor (CAR) T cells, have already

Tulane University Leads $500M Charity Hospital Redevelopment
Management & Regulatory Tulane University Leads $500M Charity Hospital Redevelopment

The towering Art Deco facade of the historic Charity Hospital has stood as a silent sentinel over the New Orleans skyline for decades, but it is now undergoing a massive five hundred million dollar transformation led by Tulane University. This ambitious redevelopment project seeks to convert the

Ananda Pharma Advances MRX1 CBD Solution to Phase II Trials
Research & Development Ananda Pharma Advances MRX1 CBD Solution to Phase II Trials

The landscape of botanical medicine underwent a massive transformation as pharmaceutical-grade cannabinoid research transitioned from niche experimentation to a cornerstone of modern therapeutic development. Ananda Pharma has positioned itself at the forefront of this evolution by announcing the

Liquid Handling Workstation Market to Reach $1.85 Billion by 2035
Management & Regulatory Liquid Handling Workstation Market to Reach $1.85 Billion by 2035

Modern laboratory environments are undergoing a quiet yet profound transformation as the reliance on manual pipette-wielding technicians gives way to a new era of robotic precision and high-throughput automation. This evolution is not merely a convenience but a structural necessity in a landscape

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later